Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Keziah Cook, Shaun P. Forbes, Kelly Adamski, Janice J. Ma, Anita Chawla & Louis P. Garrison$suffix/text()$suffix/text(). (2020) Assessing the potential cost-effectiveness of a gene therapy for the treatment of hemophilia A. Journal of Medical Economics 23:5, pages 501-512.
Read now
Read now
Kapil Saxena. (2013) Barriers and perceived limitations to early treatment of hemophilia. Journal of Blood Medicine 4, pages 49-56.
Read now
Read now
M. DeKoven, T. Wisniewski, A. Petrilla, N. Holot, W. C. Lee & D. Cooper. (2012) Patient/caregiver perceived benefits and barriers to elective orthopedic surgery (EOS) in patients with congenital hemophilia with inhibitors. Journal of Medical Economics 15:2, pages 305-312.
Read now
Read now
Articles from other publishers (25)
Rong Chen, Dmitry Gultyaev, Johanna Lister, Rong Han, Nan Hu, Jean Malacan, Alexander Solms, Parth Vashi, Jamie O’Hara & Shanlian Hu. (2022) Pharmacokinetic parameter driven outcomes model predicts a reduction in bleeding events associated with BAY 81–8973 versus antihemophilic factor (recombinant) plasma/albumin-free method in a Chinese healthcare setting. BMC Medical Research Methodology 22:1.
Crossref
Crossref
Renske M.T. ten Ham, Simon M. Walker, Marta O. Soares, Geert W.J. Frederix, Frank W.G. Leebeek, Kathelijn Fischer, Michiel Coppens & Stephen J. Palmer. (2022) Modeling Benefits, Costs, and Affordability of a Novel Gene Therapy in Hemophilia A. HemaSphere 6:2, pages e679.
Crossref
Crossref
Hankil Lee, Hyeonseok Cho, Jung Woo Han, Ah‐Young Kim, Seonyoung Park, Minjun Lee, Sunghwa Cho, Deborah Baik & Hye‐Young Kang. (2020) Cost‐utility analysis of emicizumab prophylaxis in haemophilia A patients with factor VIII inhibitors in Korea. Haemophilia 27:1.
Crossref
Crossref
Gurhan Erturan, Borna Guevel, Abtin Alvand & Nicholas J. Goddard. (2019) Over two decades of orthopaedic surgery in patients with inhibitors-Quantifying the complication of bleeding. Haemophilia 25:1, pages 21-32.
Crossref
Crossref
Bijan J. Teja, Tori N. SutherlandSheila R. Barnett & Daniel S. Talmor. (2018) Cost-Effectiveness Research in Anesthesiology. Anesthesia & Analgesia 127:5, pages 1196-1201.
Crossref
Crossref
M. Drummond, N. Houwing, U. Slothuus & P. Giangrande. (2017) Making economic evaluations more helpful for treatment choices in haemophilia. Haemophilia 23:2, pages e58-e66.
Crossref
Crossref
Ulla K.E. Hedner. 2017. Treating Life-Threatening Bleedings. Treating Life-Threatening Bleedings
157
166
.
Chien-Min Chen, Yao-Hsu Yang, Chia-Hao Chang, Chih-Cheng Chen & Pau-Chung Chen. (2016) The Utilization of Rehabilitation in Patients with Hemophilia A in Taiwan: A Nationwide Population-Based Study. PLOS ONE 11:9, pages e0164009.
Crossref
Crossref
P. Tobase, H. Lane, A.‐E‐A. Siddiqi, R. Ingram‐Rich & R. S. Ward. (2016) Declining trends in invasive orthopedic interventions for people with hemophilia enrolled in the Universal Data Collection program (2000–2010). Haemophilia 22:4, pages 604-614.
Crossref
Crossref
A. Thès, V. Molina & T. Lambert. (2015) L’arthroplastie bilatérale simultanée de genou chez l’hémophile sévère diminue les coûts de prise en charge. Revue de Chirurgie Orthopédique et Traumatologique 101:2, pages 105-108.
Crossref
Crossref
A. Thès, V. Molina & T. Lambert. (2015) Simultaneous bilateral total knee arthroplasty in severe hemophilia: A retrospective cost-effectiveness analysis. Orthopaedics & Traumatology: Surgery & Research 101:2, pages 147-150.
Crossref
Crossref
Françoise Boehlen, Lukas Graf & Erik Berntorp. (2014) Outcome measures in haemophilia: a systematic review. European Journal of Haematology 93, pages 2-15.
Crossref
Crossref
J. J. van Veen, R. M. Maclean, K. K. Hampton, A. Hamer & M. Makris. (2014) Major surgery in severe haemophilia A with inhibitors using a recombinant factor VIIa and activated prothrombin complex concentrate hybrid regimen. Haemophilia 20:4, pages 587-592.
Crossref
Crossref
Richard Wallensten. 2014. European Surgical Orthopaedics and Traumatology. European Surgical Orthopaedics and Traumatology
319
330
.
PJ Jenkins, I Ekrol & GM Lawson. (2013) Total knee replacement in patients with haemophilia: the Scottish experience. Scottish Medical Journal 58:4, pages 223-227.
Crossref
Crossref
S. A. Brown, C. Barnes, J. Curtin, S. Dunkley, P. Ockelford, J. Phillips, J. Rowell, M. Smith & H. Tran. (2012) How we use recombinant activated Factor VII in patients with haemophilia A or B complicated by inhibitors. Internal Medicine Journal 42:11, pages 1243-1250.
Crossref
Crossref
Jason M. Ali, Alan J. Howieson, Kingsley Lawrence, Dipti Chitnavis & Jai Chitnavis. (2012) Total Knee Arthroplasty in a Patient With Hemophilic Arthropathy and High-Titer Inhibitors. The Journal of Arthroplasty 27:7, pages 1413.e11-1413.e14.
Crossref
Crossref
H. CAVIGLIA, P. NARAYAN, A. FORSYTH, P. GIANGRANDE, M. GILBERT, N. GODDARD, K. MULDER & S. RAHIM. (2012) Musculoskeletal problems in persons with inhibitors: How do we treat?. Haemophilia 18, pages 54-60.
Crossref
Crossref
H. CAVIGLIA, M. CANDELA, G. GALATRO, D. NEME, N. MORETTI & R. P. BIANCO. (2011) Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature. Haemophilia 17:6, pages 910-919.
Crossref
Crossref
Matthew I. Stein, Justin Park & Stephen Raterman. (2011) Prevention of VTE Following Total Hip and Knee Arthroplasty in Hemophilia Patients. Orthopedics 34:5, pages 389-392.
Crossref
Crossref
Hilal Maradit Kremers, Sherine E. Gabriel & Michael F. Drummond. 2011. Rheumatology. Rheumatology
23
28.e5
.
Qizhen Shi & Robert R. Montgomery. (2010) Platelets as delivery systems for disease treatments. Advanced Drug Delivery Reviews 62:12, pages 1196-1203.
Crossref
Crossref
U. KHAN, C. BOGUE, W. J. UNGAR, P. HILLIARD, M. CARCAO, R. MOINEDDIN & A. S. DORIA. (2010) Cost‐effectiveness analysis of different imaging strategies for diagnosis of haemophilic arthropathy. Haemophilia 16:2, pages 322-332.
Crossref
Crossref
Pier M. Mannucci, Roger E. G. Schutgens, Elena Santagostino & Evelien P. Mauser-Bunschoten. (2009) How I treat age-related morbidities in elderly persons with hemophilia. Blood 114:26, pages 5256-5263.
Crossref
Crossref
P. O. BONNET, B. S. YOON, W.-Y. WONG, K. BOSWELL & B. M. EWENSTEIN. (2009) Cost minimization analysis to compare activated prothrombin complex concentrate (APCC) and recombinant factor VIIa for haemophilia patients with inhibitors undergoing major orthopaedic surgeries. Haemophilia 15:5, pages 1083-1089.
Crossref
Crossref